Scinai

scinai immunotherapeutics ltd. (nasdaq: scni) is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (i&i) biological products primarily for the treatment of autoimmune and infectious diseases. with a state-of-the-art facility for biopharmaceutical product development and manufacturing and highly experienced pharmaceutical industry leadership, scinai offers end-to-end boutique cdmo services in parallel to developing its own pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized vhh antibody (nanoab) pipeline targeting diseases with large unmet medical needs. company website: www.scinai.com